Second primary malignancies in myeloproliferative neoplasms and the role of aspirin
Crossref DOI link: https://doi.org/10.1038/s41375-019-0553-2
Published Online: 2019-08-21
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lucijanic, Marko http://orcid.org/0000-0002-1372-2040
Skelin, Marko
Kusec, Rajko
Text and Data Mining valid from 2019-08-21
Version of Record valid from 2019-08-21
Article History
Received: 18 June 2019
Accepted: 27 June 2019
First Online: 21 August 2019